Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm Metastasis × pyrotinib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 9 HER2-positive Breast Cancer 4 Salivary Gland Neoplasms 1 Non-squamous NSCLC 1 Non Small Cell Lung 1 Locally Advanced Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane 1 HER2 Positive Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Invasive 1 Breast Cancer Female 1 Advanced Digestive System Tumor 1 Advanced Breast Cancer 1

Interventions

pembrolizumab 87 Specimen Handling 51 Magnetic Resonance Spectroscopy 45 Nivolumab 44 Biopsy 43 Radiosurgery 29 Gemcitabine 27 Paclitaxel 26 Ipilimumab 22 Carboplatin 21 trastuzumab deruxtecan 20 Irinotecan 20 Cisplatin 20 Capecitabine 19 Leucovorin 18 Fluorouracil 17 Cyclophosphamide 17 Fulvestrant 16 Docetaxel 16 atezolizumab 15 Drug Therapy 15 Bevacizumab 15 Pemetrexed 14 Oxaliplatin 14 Cetuximab 14 130-nm albumin-bound paclitaxel 14 abemaciclib 13 Taxes 12 Radiotherapy 12 palbociclib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡